Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb IschemiaMartin Teraa, Marianne C. Verhaar, Ralf W. Sprengers et al.|Circulation|2015Cited by 181
C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular DiseaseP.M. Burger, Stefan Koudstaal, Arend Mosterd et al.|Journal of the American College of Cardiology|2023Cited by 134
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease LocationsP.M. Burger, Frank L.J. Visseren, Aruna D. Pradhan et al.|The American Journal of Cardiology|2023Cited by 66
Colchicine for secondary prevention of vascular events: a meta-analysis of trialsMarc-André d’Entremont, Sanjit S. Jolly, Kevin E. Boczar et al.|European Heart Journal|2025Cited by 43
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseaseP.M. Burger, Jeroen Schaap, Jannick A N Dorresteijn et al.|European Journal of Preventive Cardiology|2023Cited by 16